Confluence Investment Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $15M | Sell |
|
|||||
|
2025
Q2 | $14.8M | Buy |
|
|||||
|
2025
Q1 | $14.5M | Buy |
|
|||||
|
2024
Q4 | $17.2M | Sell |
|
|||||
|
2024
Q3 | $18.7M | Sell |
|
|||||
|
2024
Q2 | $19.7M | Sell |
|
|||||
|
2024
Q1 | $26.3M | Sell |
|
|||||
|
2023
Q4 | $23M | Sell |
|
|||||
|
2023
Q3 | $19.7M | Buy |
|
|||||
|
2023
Q2 | $17.7M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $51.8M | Sell |
|
|||||
|
2021
Q2 | $68.6M | Sell |
|
|||||
|
2021
Q1 | $56.8M | Sell |
|
|||||
|
2020
Q4 | $49M | Sell |
|
|||||
|
2020
Q3 | $45.1M | Sell |
|
|||||
|
2020
Q2 | $36.1M | Buy |
|
|||||
|
2020
Q1 | $21M | Buy |
|